120 related articles for article (PubMed ID: 27011226)
1. Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review.
Peinemann F; van Dalen EC; Berthold F
Klin Padiatr; 2016 Apr; 228(3):124-9. PubMed ID: 27011226
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
Peinemann F; van Dalen EC; Tushabe DA; Berthold F
Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.
Peinemann F; van Dalen EC; Enk H; Berthold F
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010685. PubMed ID: 28840597
[TBL] [Abstract][Full Text] [Related]
4. Rapid COJEC Induction Therapy for High-risk Neuroblastoma Patients - Cochrane Review.
Peinemann F; van Dalen EC; Berthold F
Klin Padiatr; 2016 Apr; 228(3):130-4. PubMed ID: 27043079
[TBL] [Abstract][Full Text] [Related]
5. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
Matthay KK; Villablanca JG; Seeger RC; Stram DO; Harris RE; Ramsay NK; Swift P; Shimada H; Black CT; Brodeur GM; Gerbing RB; Reynolds CP
N Engl J Med; 1999 Oct; 341(16):1165-73. PubMed ID: 10519894
[TBL] [Abstract][Full Text] [Related]
6. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
7. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Park JR; Villablanca JG; London WB; Gerbing RB; Haas-Kogan D; Adkins ES; Attiyeh EF; Maris JM; Seeger RC; Reynolds CP; Matthay KK;
Pediatr Blood Cancer; 2009 Jan; 52(1):44-50. PubMed ID: 18937318
[TBL] [Abstract][Full Text] [Related]
8. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
Seeger RC; Reynolds CP; Gallego R; Stram DO; Gerbing RB; Matthay KK
J Clin Oncol; 2000 Dec; 18(24):4067-76. PubMed ID: 11118468
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
10. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].
Tang SQ; Huang DS; Wang JW; Zhang XF; Liu LZ; Yu F; Yang G
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):486-9. PubMed ID: 15324562
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
[TBL] [Abstract][Full Text] [Related]
14. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Modak S; Kramer K; Roberts SS; Basu EM; Yataghene K; Cheung NK
Oncotarget; 2016 Jan; 7(4):4155-66. PubMed ID: 26623730
[TBL] [Abstract][Full Text] [Related]
15. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
16. Delayed surgery and bone marrow transplantation for widespread neuroblastoma.
Moss TJ; Fonkalsrud EW; Feig SA; Lenarsky C; Selch M; Wells J; Seeger RC
Ann Surg; 1987 Oct; 206(4):514-20. PubMed ID: 3310932
[TBL] [Abstract][Full Text] [Related]
17. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
Saarinen-Pihkala UM; Hovi L; Koivusalo A; Jahnukainen K; Karikoski R; Sariola H; Wikström S
Pediatr Blood Cancer; 2012 Dec; 59(7):1190-7. PubMed ID: 22492714
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
19. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
Matthay KK
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
